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Abstract
Hepatic tumors in children account for only 1 to 5% of all pediatric tumors. Hepatic hemangioma is,
however, the third most common tumor of the liver in childhood. We report a case of an antenatal
diagnosis of a hepatic tumor detected on a first obstetric ultrasound, at 26
th week of gestation. It
revealed a complex, predominantly solid hepatic lesion with 3 × 3 cm and a marked, essentially
peripheral, Doppler blood flow. Fetal echocardiography showed a normal heart besides a vena cava
displacement by the hepatic mass. Fetal Hepatic hemangioma was suspected. Follow-up ultrasounds
were unchanged. Pregnancy evolved well. At 36 weeks of gestation was spontaneously delivered a
3300 g boy whose examination revealed a visible thoracoabdominal circulation and a palpable liver.
No skin lesions, namely hemangiomas or petechiae were identified. Postnatal magnetic resonance
imaging confirmed the diagnosis of Hepatic hemangioma. Treatment was initiated with prednisolone
followed by interferon. After 2 years, there is no active lesion.
Introduction
Hepatic tumors in children account for only 1 to 5% of all
pediatric tumors. Hepatic Hemangioma (HH) is, however,
the third most common tumor of the liver in childhood
[1-3]. It is a proliferative endothelial cell lesion with
characteristic initial rapid growth followed by frequent
spontaneous involution. Replacing the old and contro-
versial nomenclature (“hepatic hemangioendothelioma”)
emerged the latter classification of vascular anomalies, as
proposed by Mulliken and Glowacki and by the Interna-
tional Society for the Study of Vascular Anomalies (ISSVA)
[3,4]. Two different types of hemangiomas that may affect
the liver in children were introduced: infantile hemangio-
mas and congenital hemangiomas. The latter may be
Rapidly Involuting congenital hemangioma (RICH) or
Noninvoluting congenital hemangioma (NICH).
While small HH can be asymptomatic lesions incidentally
discovered during imaging of the abdomen, larger tumors
may act as arteriovenous shunts resulting in high-output
congestive heart failure and hepatic dysfunction that may
lead to fetal non-immune hydrops (unrelated to Rh
disease). Other complications include coagulopathy,
hemolytic anemia and tumor rupture. Diagnosis is most
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tric and postnatal ultrasound, computed tomography and
magnetic resonance imaging) [5-7]. Biopsy should be used
in selected cases as it may result in massive haemorrhage.
Naturalhistoryofsmall,asymptomaticHHisspontaneous
involution and no treatment is required. Larger or
symptomatic lesions need aggressive management which
may include medical therapy with corticosteroids (CS) or
agents with strong antiangiogenic effect (interferon alpha,
cyclophosphamide, vincristine or actinomycin D), irradia-
tion, selective embolization or surgical intervention




woman presented for an obstetric ultrasound at 26 weeks
of gestational age (GA) to an outpatient sonography
department. Until then she had no pregnancy surveillance.
A complex, predominantly solid hepatic lesion was noted,
measuring approximately 3 cm in diameter. No other fetal
anatomic abnormalities were detected.
The patient was referred to our centre and a follow-up
ultrasound at 30
th gestational week revealed a hetero-
geneous, predominantly solid hepatic lesion with mostly
hypoechoic texture, a diameter of 3 cm and a marked,
essentially peripheral, Doppler blood flow (Figure 1).
Fetal Hepatic hemangioma was suspected.
Fetal echocardiography showed a normal heart with
vena cava displacement by the hepatic mass. Obstetric
ultrasound repeated at 33 weeks GA showed similar
characteristics of the hepatic formation, with an average
fetal growth and a normal umbilical artery Doppler.
GestationalDiabeteswasdiagnosedat34weeksGA,withno
need for insulinotherapy. There was no other pregnancy-
related complication.
Follow-up ultrasound at 35
th gestational week was
unchanged. At 36 weeks of gestation was spontaneously




Newborn physical examination revealed a visible
thoracoabdominal circulation, abdominal distension
and a palpable liver. No skin lesions, namely hemangio-
mas or petechiae were identified.
Besides an abnormal gamma-glutamyltransferase, labora-
tory data was unremarkable (Table 1). Chest and abdom-
inal radiography were normal. Postnatal abdominal
ultrasoundrevealed a 5 cmheterogeneous lesion occupying
essentially the hepatic caudate lobe, showing marked
hepatopetal blood flow (Figure 2).
Unenhanced magnetic resonance imaging (MRI) showed a
nodular mass with 7.3×5.1 cm affecting both lobes of the
liver with involvement of celiac trunk and hepatic hilum,
marked by low signal intensity on T1-weighted images and
high signal intensity on T2-weighted images (Figures 3, 4).
After intravenous contrast administration the lesion
revealed peripheral enhancement with centripetal filling
(slow wash-out) (Figure 5). Because of the increased
vascular supply, the tumor was associated with a striking
decrease in the aortic calibre distal to the celiac artery
origin. A deterioration of the liver function tests (LFTs) was
verified, with a considerable increase in liver and chole-
static enzymes (Table 1).
Treatment was initiated with prednisolone (3 mg/Kg/day)
but after 4 months the lesion showed the same character-
istics, with a sustained deterioration of LFTs. An alternative
medical treatment with subcutaneous a-2a-interferon was
then started; beginning with 500.000 U/m
2/day with daily
dose increased up to 1 MU/m
2/day for 3 months, with
progressive regression of the hepatic tumor and LFTs.
Besides clinical surveillance, LFTs and MRI were used in
follow-up.After2yearstheboyisasymptomatic,withnormal
LFTs (Table 1) and with last MRI control showing a nodular
hepatic lesion between left and middle hepatic artery,
measuring 1.5×0.9×0.5 cm suggesting residual hemangioma.
Discussion
Hepatic Hemangioma is a rare benign neoplasia repre-
senting, however, the most common vascular tumor of the
Figure 1. Hepatic lesion at prenatal ultrasound.
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Glowacki and according to the International Society for
the Study of Vascular Anomalies (ISSVA) [3,4], heman-
giomas that may affect the liver in children can be
classified as: infantile hemangiomas and congenital
hemangiomas. When large enough, this tumor can act as
an arterio-venous shunt and cause serious consequences
in utero and post-natally. Some case reports of antenatal
ultrasound diagnosis have been described showing the
enormous value of a previous evaluation by allowing the
pediatric team to be prepared.
Since biopsy may result in massive haemorrhage, diag-
nosis is most often based on characteristic radiological
findings [5-7]. A postnatal evaluation of the tumor,
namely with MRI, is essential to decide what is the best
treatment strategy (expectant, medical, surgical) as this is
considered the technique of choice for imaging of hepatic
vascular lesions [8].
In our case, a complex fetal hepatic lesion was diagnosed
at an obstetric ultrasound performed at 26 weeks GA.
Differential diagnosis included benign and malignant
conditions such as congenital hemangioma, mesenchymal
hamartoma, hepatoblastoma and embryonal sarcoma.
The strongest alternative diagnosis for this large, solitary,
stable lesion was hemangioma. In fact, the stabilized
growth of the lesion with no associated anomalies allowed
a more confident surveillance of the pregnancy. Neonatol-
ogist team was aware of the case so that postnatal
abdominal ultrasound and MRI were promptly provided.
As MRI was consistent with HH, biopsy was avoided.
Natural history of small, asymptomatic HH is sponta-
neous involution and no treatment is required. Larger or
symptomatic lesions need aggressive management which
may include medical therapy with CS or agents with strong
antiangiogenic effect, irradiation, selective embolization
or surgical intervention [8-10].
Asitwasalarge,symptomatictumorwithadeteriorationof
the hepatic function, expectant management was excluded




th month 2 years
Hemoglobin (g/dL) 14.6 13.7 12.3 12.1 11.7
Platelets (/mm
3) 211,000 172,000 189,000 223,000 215,000
Gamma Glutamyl Transpeptidase (U/L) 682 930 1325 315 90
Alkaline Phosphatase (U/L) 93 438 523 278 153
Lactate dehydrogenase (U/L) 192 238 427 191 159
Aspartate aminotransferase (U/L) 8 216 312 174 29
Alanine aminotrasferase (U/L) 6 117 207 132 18
Total/Conjugated Bilirubin (mg/dL) 1.5/0.9 4.3/3.1 3.7/2.3 1/<0.5 <1/<0.5
Alpha-fetoprotein (ng/mL) - 18,600 10,430 358 1.3
Figure 2. Hepatic lesion at postnatal ultrasound; marked,
peripheral Doppler blood flow.
Figure 3. Lesion surrounding the hilum, similar in signal with
hepatic parenquima.
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thefirst choiceasitisassociated withfewersideeffects.The
unresponsivenesstoCSdeterminedtheuseofasecond-line
medical therapy with interferon, with very good results as
seeninliterature[10].Giventhedescriptionofrarecasesof
malignization, long term monitoring should be main-
tained at least until complete resolution.
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Figure 4. Hyperintense hepatic lesion in T2- weighted
images.
Figure 5. Homogeneous late phase enhancement.
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